Matthew Pincus

Matthew Pincus is scientific leader, QbD and digital platforms, medicines development and supply at GSK Upper Merion, King of Prussia, PA, USA.

Articles by Matthew Pincus

Standard quality control. Certification. Business, technology, internet and networking concept.| Image Credit: © photon_photo - stock.adobe.com

Digitalization of QbD Risk Assessments

ByGayathri Acharya ,Matthew Pincus,Hervé Gressard,Phil Borman

March 16th 2024

The digital transformation of quality-by-design assessment workflows can improve efficiency, reduce human errors, and facilitate integration within a much broader digital ecosystem.

Latest Updated Articles

Digitalization of QbD Risk Assessments
Published: March 16th 2024 | Updated:

Matthew Pincus

Articles by Matthew Pincus

Digitalization of QbD Risk Assessments

Latest Updated Articles

Trending on BioPharm International

Rentschler’s Time Capsule and How it Symbolizes European Biotech Progress

Analytics, Automation, and Quality Driving the Next Era of Drug Development

Therapeutic Nucleic Acids: Advanced Solutions for Downstream Processing & Analysis